SUNITINIB MALATE IN ADVANCED HEPATOCELLULAR CARCINOMA: PRELIMINARY RESULTS OF A PHASE II STUDY

被引：0
|
作者：
Basso, M. [1 ]
Iaculli, A.
Cassano, A.
Basso, M. [1 ]
d'argento, E.
Rufini, V
Astone, A.
Rapaccini, G. [1 ]
Grieco, A. [1 ]
Barone, C.
机构：
[1] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] Sunitinib malate in advanced hepatocellular carcinoma: Results of a phase II study.
    Barone, C.
    Basso, M.
    Cassano, A.
    Rufini, V.
    D'Argento, E.
    Riccardi, L.
    Schinzari, G.
    Pompili, M.
    Grieco, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] FINAL RESULTS OF A PHASE II STUDY WITH SUNITINIB MALATE IN ADVANCED HEPATOCELLULAR CARCINOMA
    Basso, Michele
    Biolato, Marco
    Forgione, Alessandra
    Marrone, Giuseppe
    Pompili, Maurizio
    Rapaccini, Gian Ludovico
    Gasbarrini, Antonio
    Barone, Carlo
    Grieco, Antonio
    [J]. HEPATOLOGY, 2010, 52 (04) : 326A - 326A
  • [3] A phase II study of sunitinib in advanced hepatocellular carcinoma
    Barone, Carlo
    Basso, Michele
    Biolato, Marco
    Pompili, Maurizio
    Rufini, Vittoria
    Miele, Luca
    Basso, Maria
    De Gaetano, Anna Maria
    Castaldi, Paola
    Iaculli, Alessandro
    Leccisotti, Lucia
    Riccardi, Laura
    Grieco, Antonio
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (08) : 692 - 698
  • [4] A phase II study of sunitinib in patients with advanced hepatocellular carcinoma
    Zhu, A. X.
    Sahani, D. V.
    di Tomaso, E.
    Duda, D.
    Sindhwani, V.
    Yoon, S. S.
    Blaszkowsky, L. S.
    Clark, J. W.
    Ryan, D. P.
    Jain, R. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Phase II trial of the efficacy and safety of sunitinib malate monotherapy in unresectable hepatocellular carcinoma
    Raymond, E.
    Faivre, S.
    Douillard, J.
    Boucher, E.
    Lim, H.
    Kim, J.
    Lanzalone, S.
    Lechuga, M.
    Bello, C.
    Chang, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII15 - VII15
  • [6] Phase II study of sunitinib malate in head and neck squamous cell carcinoma
    Nicholas W. Choong
    Mark Kozloff
    David Taber
    H. Shawn Hu
    James Wade
    Percy Ivy
    Theodore G. Karrison
    Allison Dekker
    Everett E. Vokes
    Ezra E. W. Cohen
    [J]. Investigational New Drugs, 2010, 28 : 677 - 683
  • [7] Phase II study of sunitinib malate in head and neck squamous cell carcinoma
    Choong, Nicholas W.
    Kozloff, Mark
    Taber, David
    Hu, H. Shawn
    Wade, James, III
    Ivy, Percy
    Karrison, Theodore G.
    Dekker, Allison
    Vokes, Everett E.
    Cohen, Ezra E. W.
    [J]. INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 677 - 683
  • [8] Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
    Zhu, Andrew X.
    Sahani, Dushyant V.
    Duda, Dan G.
    di Tomaso, Emmanuelle
    Ancukiewicz, Marek
    Catalano, Onofrio A.
    Sindhwani, Vivek
    Blaszkowsky, Lawrence S.
    Yoon, Sam S.
    Lahdenranta, Johanna
    Bhargava, Pankaj
    Meyerhardt, Jeffrey
    Clark, Jeffrey W.
    Kwak, Eunice L.
    Hezel, Aram F.
    Miksad, Rebecca
    Abrams, Thomas A.
    Enzinger, Peter C.
    Fuchs, Charles S.
    Ryan, David P.
    Jain, Rakesh K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 3027 - 3035
  • [9] Sunitinib monotherapy in patients with advanced hepatocellular carcinoma (HCC): Insights from a multidisciplinary phase II study
    Zhu, A. X.
    Sahani, D. V.
    di Tomaso, E.
    Duda, D. G.
    Catalano, O. A.
    Ancukiewicz, M.
    Blaszkowsky, L. S.
    Abrams, T. A.
    Ryan, D. P.
    Jain, R. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
    Faivre, Sandrine
    Raymond, Eric
    Boucher, Eveline
    Douillard, Jean
    Lim, Ho Y.
    Kim, Jun S.
    Zappa, Magaly
    Lanzalone, Silvana
    Lin, Xun
    DePrimo, Samuel
    Harmon, Charles
    Ruiz-Garcia, Ana
    Lechuga, Maria J.
    Cheng, Ann Lii
    [J]. LANCET ONCOLOGY, 2009, 10 (08): : 794 - 800
12345